Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hansen Ho

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 18, 2009
Aprepitant-associated ifosfamide neurotoxicityHansen Ho, Courtney Yuen
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 25, 2015
Combination pertuzumab, trastuzumab, and taxane for metastatic breast cancer after first progression: a single institution's experienceBao D Dao, Hansen Ho, Laura N Quintal
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
Hereditary alpha tryptasemia presenting as recurrent chemotherapy hypersensitivity reactionsRose Monahan, Emely Alfaro, Hansen Ho, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 13, 2024
Rechallenges without desensitization following platinum-based chemotherapy reactionsFernanda D Young, Sidney Aung, Monica Tang, et al.
Journal for Immunotherapy of Cancer|May 13, 2021
<i>TERT</i> promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitorIvan de Kouchkovsky, Li Zhang, Errol J Philip, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 18, 2009
Aprepitant-associated ifosfamide neurotoxicityHansen Ho, Courtney Yuen
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 25, 2015
Combination pertuzumab, trastuzumab, and taxane for metastatic breast cancer after first progression: a single institution's experienceBao D Dao, Hansen Ho, Laura N Quintal
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
Hereditary alpha tryptasemia presenting as recurrent chemotherapy hypersensitivity reactionsRose Monahan, Emely Alfaro, Hansen Ho, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 13, 2024
Rechallenges without desensitization following platinum-based chemotherapy reactionsFernanda D Young, Sidney Aung, Monica Tang, et al.
Journal for Immunotherapy of Cancer|May 13, 2021
<i>TERT</i> promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitorIvan de Kouchkovsky, Li Zhang, Errol J Philip, et al.
Pageof 1